While Active Implantable Medical Devices (AIMDs) enabled huge societal achievements since decades, new technologies are required to enlarge the therapeutic window. That is especially the ambition of the SELANT project, started in October 2020, enabling a next generation of medical implants The SEALANT consortium benefits from the proven expertise and years of experience in design, development and production of components and technologies used for active medical devices:  OSYPKA AG (DE, medical devices manufacturing), Comelec SA (CH, encapsulation solutions and OEM), University of Freiburg, Department of Microsystems Engineering (IMTEK, DE, research in MEMS-based optogenetic implants) and NMI Natural and Medical Sciences Institute (DE, research institute active in miniaturized implant encapsulation and advanced testing).